Compounds > rhenium
Page last updated: 2024-08-22

rhenium and Cancer of Ovary

rhenium has been researched along with Cancer of Ovary in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (47.62)18.2507
2000's2 (9.52)29.6817
2010's6 (28.57)24.3611
2020's3 (14.29)2.80

Authors

AuthorsStudies
Harris, HH; Huang, Z; King, AP; Lai, B; Lovett, J; Wilson, JJ; Woods, JJ1
Bileck, A; Borutzki, Y; Gerner, C; Huang, Z; Janker, L; King, AP; Marker, SC; Meier-Menches, SM; Neuditschko, B; Wilson, JJ1
Boros, E; King, AP; Marker, SC; Qian, SB; Swanda, RV; Vaughn, B; Wilson, JJ1
Chang, CH; Chang, CM; Chuang, CM; Huang, WS; Lan, KL; Lee, TW; Lee, YJ1
Chen, D; Tang, Q1
Altai, M; Honarvar, H; Larsson, E; Löfblom, J; Lubberink, M; Orlova, A; Sandström, M; Ståhl, S; Strand, J; Strand, SE; Tolmachev, V; Varasteh, Z; Wållberg, H1
Chang, CH; Chen, PH; Chuang, CM; He, CL; Lan, KL; Lee, TW; Lee, YJ; Lin, LT; Shen, YA1
Cesnavicious, J; Doyle, RP; Rabideau, AE; Viola-Villegas, N; Zubieta, J1
Ekblad, T; Karlström, AE; Orlova, A; Tolmachev, V; Tran, TA1
Chen, DZ; Gong, YC; Guo, CQ; Tang, QS; Xiang, JY; Xue, WQ; Zhang, L1
Fallone, BG; McQuarrie, SA; Middleton, JW; Syme, AM1
Breitz, HB; Durham, JS; Fisher, DR; Weiden, PL1
Breitz, HB; DeNardo, GL; Durham, JS; Fisher, DR; Goodgold, HM; Nelp, WB; Weiden, PL1
Diril, H; Goldenberg, DM; Griffiths, GL; Hansen, HJ; Mattes, MJ; Ong, GL; Shih, LB; Thorpe, SR1
Breitz, H; Cain, J; Fer, M; Goodgold, H; Heaps, J; Jacobs, AJ; Su, FM; Thompson, J; Weiden, P1
Boven, E; Kievit, E; Pinedo, HM; Schlüper, HM; van Dongen, GA; van Gog, FB2
Bier, S; Kwok, CS; Noujaim, AA; Snieckus, V; Somayaji, VV; Sykes, TR; Woo, TK1
Bundesen, PG; Schmidt, PF; Smith, SV1
Kerkvliet, GJ1

Trials

3 trial(s) available for rhenium and Cancer of Ovary

ArticleYear
Radiation-absorbed dose estimates to normal organs following intraperitoneal 186Re-labeled monoclonal antibody: methods and results.
    Cancer research, 1995, Dec-01, Volume: 55, Issue:23 Suppl

    Topics: Antibodies, Monoclonal; Female; Humans; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Rhenium

1995
Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibody.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:5

    Topics: Female; Humans; Infusions, Parenteral; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Rhenium; Tissue Distribution; Whole-Body Counting

1995
A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical response.
    Obstetrics and gynecology, 1993, Volume: 82, Issue:4 Pt 1

    Topics: Adult; Aged; Carcinoma; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Treatment Outcome

1993

Other Studies

18 other study(ies) available for rhenium and Cancer of Ovary

ArticleYear
Photochemistry and
    Chemical communications (Cambridge, England), 2021, Oct-26, Volume: 57, Issue:85

    Topics: Antineoplastic Agents; Apoptosis; Cell Membrane Permeability; Computational Biology; Coordination Complexes; Drug Screening Assays, Antitumor; Female; HeLa Cells; Humans; Light; Optical Imaging; Ovarian Neoplasms; Photochemotherapy; Platinum; Rhenium; Spectrometry, X-Ray Emission

2021
An Anticancer Rhenium Tricarbonyl Targets Fe-S Cluster Biogenesis in Ovarian Cancer Cells.
    Angewandte Chemie (International ed. in English), 2022, 10-24, Volume: 61, Issue:43

    Topics: Female; Ferritins; Humans; Iron-Sulfur Proteins; Mitochondria; Ovarian Neoplasms; Rhenium

2022
Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes.
    Angewandte Chemie (International ed. in English), 2020, 08-03, Volume: 59, Issue:32

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Coordination Complexes; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Metallothionein; NF-E2-Related Factor 2; Ovarian Neoplasms; Rhenium; Verapamil

2020
    International journal of molecular sciences, 2017, Apr-25, Volume: 18, Issue:5

    Topics: Animals; Autophagy; CA-125 Antigen; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Drug Resistance, Neoplasm; Female; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Mitochondria; Nanomedicine; Neoplastic Stem Cells; Ovarian Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Transplantation, Heterologous

2017
Study of the therapeutic effect of 188Re labeled folate targeting albumin nanoparticle coupled with cis-diamminedichloroplatinum cisplatin on human ovarian cancer.
    Bio-medical materials and engineering, 2014, Volume: 24, Issue:1

    Topics: Albumins; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Combined Modality Therapy; Drug Carriers; Female; Folic Acid; Humans; Hyperthermia, Induced; Ligands; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Transplantation; Ovarian Neoplasms; Radioisotopes; Rhenium

2014
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:11

    Topics: Animals; Antibodies; Cell Line, Tumor; Chelating Agents; Drug Evaluation, Preclinical; Female; Gluconates; Humans; Mice; Mice, Nude; Oligopeptides; Ovarian Neoplasms; Peptides; Radiation Dosage; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptor, ErbB-2; Rhenium; Xenograft Model Antitumor Assays

2014
Intraperitoneal (188)Re-Liposome delivery switches ovarian cancer metabolism from glycolysis to oxidative phosphorylation and effectively controls ovarian tumour growth in mice.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2016, Volume: 119, Issue:2

    Topics: Animals; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Glycolysis; Humans; Liposomes; Mice; Ovarian Neoplasms; Oxidative Phosphorylation; Radiation Tolerance; Radioisotopes; Rhenium; Tumor Suppressor Protein p53

2016
Targeting the folate receptor (FR): imaging and cytotoxicity of ReI conjugates in FR-overexpressing cancer cells.
    ChemMedChem, 2008, Volume: 3, Issue:9

    Topics: Animals; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; DNA; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Electrophoretic Mobility Shift Assay; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Inhibitory Concentration 50; Intercalating Agents; Microscopy, Confocal; Molecular Structure; Organometallic Compounds; Ovarian Neoplasms; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; Rhenium; Structure-Activity Relationship; Topoisomerase I Inhibitors

2008
(186)Re-maSGS-Z (HER2:342), a potential Affibody conjugate for systemic therapy of HER2-expressing tumours.
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Female; Humans; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Organ Specificity; Ovarian Neoplasms; Radiation Dosage; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptor, ErbB-2; Rhenium; Tissue Distribution

2010
Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo.
    International journal of nanomedicine, 2011, Volume: 6

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Stability; Female; Folic Acid; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Magnetite Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Radioisotopes; Rhenium; Serum Albumin; Temperature; Tin Compounds; Tissue Distribution; Xenograft Model Antitumor Assays

2011
Dosimetric model for intraperitoneal targeted liposomal radioimmunotherapy of ovarian cancer micrometastases.
    Physics in medicine and biology, 2003, May-21, Volume: 48, Issue:10

    Topics: Biophysical Phenomena; Biophysics; CA-125 Antigen; Computer Simulation; Female; Humans; Injections, Intraperitoneal; Liposomes; Models, Biological; Ovarian Neoplasms; Peritoneal Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Rhenium

2003
The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:5

    Topics: Acetylgalactosamine; Animals; Antibodies, Monoclonal; Female; Indium Radioisotopes; Inulin; Iodine Radioisotopes; Kidney Neoplasms; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Serum Albumin, Bovine; Tumor Cells, Cultured; Tyramine

1994
Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts.
    International journal of radiation oncology, biology, physics, 1997, Jul-01, Volume: 38, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Female; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Organotechnetium Compounds; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured

1997
Radiolabeling of monoclonal antibody B43.13 with rhenium-188 for immunoradiotherapy.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 1997, Volume: 48, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Cell Line; Drug Stability; Female; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Transplantation, Heterologous

1997
[186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.
    Nuclear medicine and biology, 1998, Volume: 25, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Chelating Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Glycine; Humans; Immunotoxins; Isoelectric Point; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Radioimmunotherapy; Radioisotopes; Recombinant Fusion Proteins; Rhenium; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured

1998
188Re DD-3B6/22 Fab' for use in therapy of ovarian cancer: labelling and animal studies.
    Nuclear medicine and biology, 1998, Volume: 25, Issue:7

    Topics: Animals; Ascorbic Acid; Female; Gluconates; Immunoglobulin Fab Fragments; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Oxidation-Reduction; Radioimmunodetection; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Rhenium; Technetium

1998
Clinical trials available using radiolabeled MoAbs against colon cancer, lung cancer, ovarian cancer, and hepatic metastases.
    Oncology (Williston Park, N.Y.), 1990, Volume: 4, Issue:8

    Topics: Antibodies, Monoclonal; Clinical Trials as Topic; Colonic Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Radioisotopes; Rhenium

1990
Killer antibodies enter clinical trial against ovarian cancer.
    Journal of the National Cancer Institute, 1990, Apr-04, Volume: 82, Issue:7

    Topics: Adenocarcinoma; Antibodies, Monoclonal; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Radioisotopes; Rhenium

1990